便秘治疗市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

便秘治疗市场按治疗(泻药、氯离子通道激活剂、外周作用 Mu-阿片受体拮抗剂、GC-C 激动剂等)、疾病类型、分销渠道和地理区域划分

市场快照

Constipation Treatment Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: North America
Largest Market: Asia Pacific
CAGR: 6.9 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

由于老年人口的增加和饮食习惯的改变,IBS-C、OIC和慢性便秘的高发病率以及最新药物和治疗程序的开发等因素,便秘治疗市场将呈现快速增长。

肠易激综合征 (IBS) 被发现是一种慢性、反复发作和缓解的胃肠道功能障碍,可导致腹痛、腹胀和排便习惯改变。肠易激综合征 (IBS) 被发现影响全球高达 7%–18% 的人口,因此其患病率正在增加,这推动了整个市场。尽管市场上有几种治疗 IBS 的药物是有效的,并且需要对各种 IBS 亚型的一种或多种症状进行批准的治疗。

也有更新的药物治疗可用于便秘,在缓解便秘方面优于安慰剂。但是没有单一的方法来治疗 IBS-C。通常,人们会使用多种疗法来缓解症状。它们可以包括饮食、锻炼、压力管理和药物治疗的变化。因此,所有这些因素都与市场整体增长的增加有关。

报告范围

根据报告的范围,便秘是一种影响个人正常生活的常见疾病,长期便秘可能是更严重疾病和紊乱的症状。据估计,它会影响每个人一生一次。便秘可能是偶发的,持续数周,也可能是慢性的,持续时间较长且反复发作。因此,它也可能与其他疾病有关,例如肠易激综合征或阿片类药物消耗。

By Therapeutic
Laxatives
Chloride Channel Activators
Peripherally Acting Mu-Opioid Receptor Antagonists
GC-C Agonists
Others
By Disease Type
Chronic idiopathic constipation (CIC)
Irritable bowel syndrome with constipation (IBS-C)
Opioid-induced constipation (OIC)
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

泻药有望在预测期内主导便秘市场

根据治疗选择,全球便秘治疗市场分为泻药、外周作用 mu-阿片受体拮抗剂、氯离子通道激活剂、GC-C 激动剂和 5-HT4 受体激动剂。泻药是一种可以治疗便秘的药物。如果生活方式的改变(例如增加饮食中的纤维含量、多喝水和定期锻炼)没有帮助,则经常使用它们。

因此,在预测期内,泻药部分预计将是最有前途的,并主导市场份额。由于低成本和广泛的可用性,大众的负担能力是导致该泻药领域繁荣的两个关键因素。

Picture4.png

预计北美将在预测期内主导便秘市场

北美被认为是该市场最大的增长区域,这主要是由于慢性便秘患病率的增加和医疗保健投资的增长。此外,由于存在大量生产便秘药物的市场参与者等因素,美国在北美地区拥有最大的市场份额。 

亚太地区也有望成为增长最快的市场,其增长归因于对诊断测试的巨大需求以及对胃肠道疾病早期诊断和治疗的日益关注。

Picture18.png

竞争格局

制造商正在大力投资开发新型便秘治疗药物,预计将巩固全球市场。治疗便秘的治疗药物制造商的这些热心努力有助于全球市场的增长。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Geriatric Population and Changing Dietary Habits

      2. 4.2.2 High Prevalence of IBS-C, OIC and Chronic Constipation

      3. 4.2.3 Development of Latest Drugs and Treatment Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 Increasing Dependence on Majority of Over-the-Counter (OTC) Drugs

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Therapeutic

      1. 5.1.1 Laxatives

      2. 5.1.2 Chloride Channel Activators

      3. 5.1.3 Peripherally Acting Mu-Opioid Receptor Antagonists

      4. 5.1.4 GC-C Agonists

      5. 5.1.5 Others

    2. 5.2 By Disease Type

      1. 5.2.1 Chronic idiopathic constipation (CIC)

      2. 5.2.2 Irritable bowel syndrome with constipation (IBS-C)

      3. 5.2.3 Opioid-induced constipation (OIC)

    3. 5.3 By Distribution Channel

      1. 5.3.1 Hospital Pharmacies

      2. 5.3.2 Retail Pharmacies

      3. 5.3.3 Online Pharmacies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Takeda Pharmaceutical Company Ltd.

      2. 6.1.2 Ironwood Pharmaceuticals, Inc.

      3. 6.1.3 Salix Pharmaceuticals, Inc.

      4. 6.1.4 Abbott Laboratories

      5. 6.1.5 AstraZeneca Plc

      6. 6.1.6 Cosmo Pharmaceuticals NV

      7. 6.1.7 Sanofi S.A.

      8. 6.1.8 Bayer AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Constipation Treatment Market market is studied from 2018 - 2026.

The Constipation Treatment Market is growing at a CAGR of 6.9% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

Asia Pacific holds highest share in 2021.

Takeda Pharmaceutical Company Ltd, Ironwood Pharmaceuticals, Inc., AstraZeneca Plc, Salix Pharmaceuticals, Sanofi S.A. are the major companies operating in Constipation Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!